Don’t be patient with the Woodford Patient Capital Trust

The Woodford Patient Capital investment trust continues to remain in limbo. Don’t bet on a turnaround anytime soon.

Neil Woodford © Shutterstock

Neil Woodford's woes have continued this week, with the latest grim half-year results from the investment trust he manages, Woodford Patient Capital Trust. For a full update, see below, but there are three key lessons investors should learn from this debacle.

Watch what managers do, not what they say

In the half-year report, Woodford says he still believes the trust "will ultimately reward the patient investor". Yet he sold £1m roughly 60% of his holding of shares in Patient Capital in July. Apparently it was to pay a tax bill, but given that Woodford is not short of a bob or two, it seems odd he couldn't find another way to raise the funds. Anyone with an ounce of scepticism has to question whether he has any real faith in the trust.

Subscribe to MoneyWeek

Become a smarter, better informed investor with MoneyWeek.

The less liquid the asset, the less reliable the valuation

Because investment trusts are listed companies, the share price has no direct link to the value of the underlying portfolio (the net asset value, or NAV). So sometimes the trust will trade at a discount to the NAV, enabling you to pick up £1-worth of assets for, say, 90p. But can you trust the NAV? If the fund runs a portfolio of FTSE 100 stocks, the answer is "yes" you can get an independent, rapidly-updated valuation almost instantly. But if the portfolio is made up of private firms, then the valuation is not only static for months at a time, it is also merely the opinion of a handful of individuals, which can never match the "wisdom of crowds". The fact that Patient Capital's NAV has been revised down from 97p at the start of this year to 65p today just nine months later! shows that the wide discount does not indicate a bargain it indicates a NAV that simply cannot be trusted.

Turnarounds don't start until the "kitchen sink" moment

If Patient Capital is to have any hope of rehabilitation, then Woodford needs to go, and a new manager needs to come in and ruthlessly assess the portfolio. That would be very painful, but it would give the market a sense of confidence in whatever value is deemed to remain in the trust. The fact that Woodford is still in place as manager points to two scenarios, neither of which is reassuring for investors. The board may still be overly influenced by Woodford it's hard to fire a manager at the best of times, let alone when his name is on the trust. But even more worryingly, the board may simply be struggling to find another manager to take the trust on. Given the mess they'd inherit, that's perhaps no surprise.

Advertisement
Advertisement - Article continues below

In short, we wouldn't go near it and probably won't re-evaluate that view until Woodford is gone (assuming that ever happens). Avoid if you don't own sell if you do.

Why Woodford Patient Capital might struggle to take a long-term view

In June, Neil Woodford had to suspend his Woodford Equity Income fund. The open-ended fund held too many illiquid assets that he was unable to sell rapidly enough to fund a flood of people asking for their money back. The fund remains closed to withdrawals.

Technically, as an investment trust, Woodford Patient Capital doesn't have this problem to get out, you just sell your shares on the stockmarket. But liquidity is still proving a headache in other ways.

Firstly, the fact that the income fund and the trust share a lot of overlapping holdings ones that the income fund is under pressure to sell means the valuation of each of these companies (most of which are hard to value at the best of times) is under real pressure. This has been one driver of the huge write down in the trust's net asset value (NAV) since the start of the year (see above).

Another problem is that the trust has employed "gearing" ie, it has invested using borrowed money. This borrowing facility is limited to 20% of NAV. The trouble is, that means that if the NAV falls, the gearing must be cut. That in turn puts pressure on the trust to sell off assets exactly the scenario that an investment trust is designed to avoid. So much for long-term capital.

The trust is trying to tackle this in two ways. Firstly, it is likely to propose changing its investment policy to allow unlisted companies to exceed 80% of the portfolio's value (Alan Brierley of Investec tells The Times that, save for the listing of a big holding on the obscure Nex exchange, the trust's illiquid holdings already run at 90%). This will mean the more liquid shares can be sold to pay down borrowing.

Advertisement
Advertisement - Article continues below

Secondly, the trust needs to renew its borrowing facility by 16 January next year. As Matthew Vincent points out in the Financial Times's Lombard column, this short-term deadline, rather than long-term investing, is now the board's main priority.

Advertisement

Recommended

Visit/investments/funds/neil-woodford/600717/woodford-investor-your-first-payment-is-coming-soon
Neil Woodford

Woodford investor? Your first payment is coming soon

Private investors left stranded by the collapse of the Woodford Equity Income fund will soon be getting at least some of their money back. But they wi…
28 Jan 2020
Visit/520181/how-the-fear-of-death-affects-your-investment-process
Investment strategy

How the fear of death affects our investment processes

Many of our investment decisions are driven by one simple fact: the knowledge that, one day, we will be dead. Here, in an extract from his new book, J…
2 Jan 2020
Visit/520127/neil-woodford-rides-again
People

Neil Woodford rides again

Neil Woodford’s speedy descent made Icarus look like a slouch. Many thought he would now be spending more time with his horses. He’s actually plotting…
1 Jan 2020
Visit/520060/the-good-and-the-bad-investments-of-2010s
Stock markets

The good investments of the 2010s – and the bad

John Stepek takes a look back on which investments did well and which did badly in the decade that’s about to come to an end.
26 Dec 2019

Most Popular

Visit/personal-finance/pensions/pension-tax/600877/why-it-makes-sense-to-scrap-higher-rate-pensions-tax
Pension tax

Why it makes sense to scrap higher-rate pensions tax relief

The point of pensions tax relief is to keep you out of the means-tested benefits system. The current system is ridiculously generous, says Merryn Some…
24 Feb 2020
Visit/investments/property/buy-to-let/600849/come-back-buy-to-letters-all-is-forgiven
Buy to let

Come back buy-to-letters, all is forgiven

The government is winning its war against small private buy-to-let landlords. But who benefits?
23 Feb 2020
Visit/investments/commodities/gold/600887/gold-price-coronavirus-cost-of-face-masks
Gold

Gold, coronavirus, and the high cost of face masks in northern Italy

The price of gold is spiking – as it always does in a global panic. But this bull market predates the coronavirus epidemic, says Dominic Frisby, and w…
26 Feb 2020
Visit/investments/stockmarkets/european-stockmarkets/600725/is-2020-the-year-for-european-small-cap
Sponsored

Is 2020 the year for European small-cap stocks?

SPONSORED CONTENT - Ollie Beckett, manager of the TR European Growth Trust, on why he believes European small-cap stocks are performing well.
12 Feb 2019